OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Piramal Pharma's OCF Yield % or its related term are showing as below:
NSE:PPLPHARMA'
s OCF Yield % Range Over the Past 10 Years
Min: 7 Med: 0 Max: 7
Current: 7
During the past 6 years, the highest OCF Yield % of Piramal Pharma was 7.00%. The lowest was 7.00%. And the median was %.
NSE:PPLPHARMA's OCF Yield % is ranked better than 69.81% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 3.51
vs NSE:PPLPHARMA: 7.00
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Piramal Pharma OCF Yield % Related Terms
Piramal Pharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for Piramal Pharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:PPLPHARMA vs ZTS, UTHR: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Piramal Pharma OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Piramal Pharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piramal Pharma (NSE:PPLPHARMA) has a OCF Yield % of 7.00 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Piramal Pharma and its competitors. Over the past decade, Piramal Pharma's OCF Yield % has ranged from 7.00 to 7.00. According to the industry distribution chart, Piramal Pharma ranks #304 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 30.2%.
Is Piramal Pharma's OCF Yield % too high?
Piramal Pharma's current OCF Yield % is 7.00. Over the past 10 years, this metric has ranged from a low of 7.00 to a high of 7.00. The Drug Manufacturers industry median OCF Yield % is 3.51. Piramal Pharma's value of 7.00 is 99.4% above this industry median. Based on the distribution chart, Piramal Pharma ranks #304 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Piramal Pharma has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Piramal Pharma's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Piramal Pharma ranks #304 out of 1007 companies for OCF Yield %. This puts Piramal Pharma in the upper half of its industry. The industry median OCF Yield % is 3.51. Piramal Pharma's value of 7.00 is 99.4% above this benchmark. Historically, Piramal Pharma's own OCF Yield % has ranged from 7.00 to 7.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.51, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Piramal Pharma's current OCF Yield % of 7.00 is 99.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Piramal Pharma and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Piramal Pharma's current OCF Yield % is 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piramal Pharma stock overvalued right now?
Based on GuruFocus' analysis, Piramal Pharma (NSE:PPLPHARMA) is currently considered Fairly Valued. The stock's GF Value™ is ₹174.09, compared to a current price of ₹177.88 — trading 2.2% above its estimated fair value. The current OCF Yield % is 7.00 and 99.4% above the Drug Manufacturers industry median of 3.51. Piramal Pharma's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Piramal Pharma (NSE:PPLPHARMA), the current OCF Yield % is 7.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Piramal Pharma (NSE:PPLPHARMA) Overvalued in 2026?
Based on GuruFocus' analysis, Piramal Pharma stock appears to be overvalued.
The current stock price of ₹177.88 is trading 2.2% above its estimated GF Value™ of ₹174.09.
GuruFocus considers Piramal Pharma to be Fairly Valued.
Key valuation signals for NSE:PPLPHARMA:
OCF Yield %: 7.00
GF Value™: ₹174.09 vs. price of ₹177.88 (2.2% above fair value)
Industry Position: 99.4% above the Drug Manufacturers median (#304 of 1007)
No single metric tells the full story. See the NSE:PPLPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.
58GF Score
Get the complete analysis for NSE:PPLPHARMA
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PPLPHARMA has been successfully added to your 
